A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
12/2011
12/21/2011	CN101869574B 哇巴因在增强非小细胞肺癌细胞敏感性中的应用 Wow Pakistan due to the application in non-small cell lung cancer cells to enhance the sensitivity of the
12/21/2011	CN101843582B 紫杉醇纳米混悬剂及其制备方法 Taxol nanosuspension and its preparation method
12/21/2011	CN101716199B 一种从木芙蓉叶中提取黄酮类化合物的方法 A method of extracting flavonoids from hibiscus leaves
12/21/2011	CN101704817B 苦参碱类化合物及其制备方法与应用 Matrine compound and its preparation method and application
12/21/2011	CN101684115B 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途 4- (5 - ((2- (4-morpholino-6-phenyl-1,3,5-triazin-2-yl) hydrazono) methyl) furan-2-yl) benzoic acid, their preparation and use
12/21/2011	CN101623443B 治疗恶性肿瘤放、化疗后气阴两虚证的中药组合物及其制备方法 Treatment of cancer radiotherapy and chemotherapy Qi Deficiency of Chinese medicine composition and its preparation method
12/21/2011	CN101612183B 一种乌骨藤皂苷提取物、药物组合物、制备方法及其应用 One kind of black bone vine saponin extract, pharmaceutical compositions, preparation method and application
12/21/2011	CN101574326B 一种含替加氟、吉美斯他和氧嗪酸钾的胶囊制剂及其制备方法 An tegafur, Kyrgyzstan Gomez him and oteracil potassium-containing capsule and its preparation method
12/21/2011	CN101475630B 牛蛙抗菌肽temporin-La及其基因和在制药中的应用 Bullfrog temporin-La antimicrobial peptide gene and its application in pharmacy
12/21/2011	CN101445499B 一种二萜类抗肿瘤化合物及其制备方法 A two terpenoids antitumor compounds and methods
12/21/2011	CN101416988B 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途 Feed oleander hawk moth larva Changchun mosaic fecal extract in the preparation of anticancer drugs in use
12/21/2011	CN101411787B 一种治疗直肠癌便血的汤剂药物 A treatment for colorectal cancer in the stool decoction drug
12/21/2011	CN101328159B 紫杉烷前体抗癌药及其药物组合物和用途 Taxane anticancer agent precursors and pharmaceutical compositions thereof and uses
12/21/2011	CN101311187B 一种雷公藤红素衍生物及其制备方法与用途 One kind Tripterine derivatives and preparation method and use
12/21/2011	CN101167831B 苹果多糖、其制备方法及在防治肿瘤转移药物中的应用 Apple polysaccharides, their preparation and use in the fight against drugs in tumor metastasis
12/21/2011	CN101111504B 伊班膦酸盐多晶型物a Ibandronate a polymorph
12/21/2011	CN101031567B 新型杂环NF-κB抑制剂 Novel heterocyclic inhibitors of NF-κB
12/20/2011	USRE43038 Compound having antitumor activity and process for producing the same
12/20/2011	US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/20/2011	US8080665 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
12/20/2011	US8080659 CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
12/20/2011	US8080657 Compounds of reverse turn mimetics and the use thereof
12/20/2011	US8080641 Process for the production of multiple cross-linked hyaluronic acid derivatives
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080635 Non-functional P2X7 receptor
12/20/2011	US8080431 Nanoparticles
12/20/2011	US8080388 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/20/2011	US8080241 Viruses for the treatment of cellular proliferative disorders
12/20/2011	CA2602738C Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
12/20/2011	CA2526211C [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof
12/20/2011	CA2468562C Hydrazonopyrazole derivatives and their use as therapeutics
12/20/2011	CA2453991C New antitumoral derivatives of et-743
12/20/2011	CA2450589C Isoxazoline compounds having mif antagonist activity
12/20/2011	CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/20/2011	CA2386858C 36p6d5: secreted tumor antigen
12/20/2011	CA2381143C Dendrimer-photosensitizer complexes for medical applications
12/20/2011	CA2321161C Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156759A1 Methods of treating hematological disorders with quinazolinone compounds in selected patients
12/15/2011	WO2011156751A2 Immunogenic vaccine
12/15/2011	WO2011156698A2 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS
12/15/2011	WO2011156518A2 Estrogen receptor modulators and uses thereof
12/15/2011	WO2011156473A1 Crystalline forms of kinase inhibitors
12/15/2011	WO2011156464A1 Crystalline forms of kinase inhibitors
12/15/2011	WO2011156461A1 Crystalline forms of kinase inhibitors
12/15/2011	WO2011156321A1 Furanyl compounds and the use thereof
12/15/2011	WO2011156119A1 Combination therapy methods for treating proliferative diseases
12/15/2011	WO2011156061A1 Preparation of crystalline ezatiostat hydrochloride ansolvate form d
12/15/2011	WO2011156025A1 Crystalline Ezatiostat Hydrochloride Ansolvate
12/15/2011	WO2011155793A2 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
12/15/2011	WO2011155643A1 Phosphatidylinositol 3-kinases activity regulator including the fifth zinc finger domain of fog2
12/15/2011	WO2011155501A1 Pharmaceutical multimeric particles, and manufacturing method for same
12/15/2011	WO2011154863A1 Her-2 peptides and vaccines
12/15/2011	WO2011154737A1 Morpholino pyrimidines and their use in therapy
12/15/2011	WO2011154485A1 Treating cancer by modulating mammalian sterile 20-like kinase 3
12/15/2011	WO2011154476A1 Anti-tumor composition
12/15/2011	WO2011154327A1 Nitrogen containing heteroaryl compounds
12/15/2011	WO2011154146A1 Parvovirus for treatment of tumours by intranasal application
12/15/2011	WO2011153942A1 Cyanoquinoline derivatives
12/15/2011	WO2011153815A1 Sialic acid (α-(2→6)-d-aminopyranose derivatives, synthesis methods and uses thereof
12/15/2011	WO2011153814A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
12/15/2011	WO2011153719A1 Smilax saponin compound
12/15/2011	WO2011133521A3 Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor
12/15/2011	WO2011130878A9 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
12/15/2011	WO2011129549A9 Anticancer drug delivery system using ph-sensitive metal nanoparticles
12/15/2011	WO2011123427A9 Treatment of cancer by inhibiting activity or expression of late sv-40 factor
12/15/2011	WO2011112607A3 NKX3-1 saRNA AND KLF4 saRNA AND USES THEREOF
12/15/2011	WO2011103016A3 Compositions and methods for inhibiting ezh2
12/15/2011	WO2011100325A3 Polymorphs of sunitinib salts
12/15/2011	WO2011100282A3 Imatinib mesylate polymorphs
12/15/2011	WO2011097384A3 Tumor targeted delivery of immunomodulators by nanoplymers
12/15/2011	WO2011096756A3 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/15/2011	WO2011096676A3 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
12/15/2011	WO2011094389A3 Cxcr4 antagonists for imaging of cancer and inflammatory disorders
12/15/2011	WO2011091065A3 Synthetic nanostructures including nucleic acids and/or other entities
12/15/2011	WO2011009903A4 Material system comprising endoperoxide adapting to decomposition, and applications
12/15/2011	WO2010129053A8 Egfr inhibitors and methods of treating disorders
12/15/2011	WO2010109115A9 Anticancer compounds, preparation thereof, and therapeutic use thereof
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110306675 Compositions and methods for inhibiting nf-kb mediated tumorigenicity and adhesion-dependent survival of cancer cells
12/15/2011	US20110306671 Amide derivatives of ethacrynic acid
12/15/2011	US20110306668 Construction and screening of solution-phase derived library of fenbufen and ethacrynic acid
12/15/2011	US20110306662 Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer
12/15/2011	US20110306658 Novel compound obtained from gamboge resin, and medical uses of the same
12/15/2011	US20110306655 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306647 Novel polymorphs of sunitinib malate
12/15/2011	US20110306640 Dabigatran in tumour therapy
12/15/2011	US20110306632 Solid Dispersions Containing Kinase Inhibitors
12/15/2011	US20110306630 Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2011	US20110306629 Novel c-1 analogs of pancratistatin and 7-deoxypancratistatin and processes for their preparation
12/15/2011	US20110306625 Compounds and compositions as protein kinase inhibitors
12/15/2011	US20110306619 6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1yl) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-b][1,3,4]thiadiazole derivatives and their use
12/15/2011	US20110306615 Novel imidazolidine derivative and use thereof
12/15/2011	US20110306613 Chemical compounds
12/15/2011	US20110306610 9-substituted 8-oxoadenine compound
12/15/2011	US20110306605 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
12/15/2011	US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011	US20110306600 Novel therapeutic compounds
12/15/2011	US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2

1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 2211